---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038583"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:07:18.673694+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics enters ATM equity offering agreement with H.C. Wainwright for up to $1.14M

## Summary
- Entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC to sell common stock shares from time to time.
- Aggregate market value of shares eligible for sale under the ATM prospectus supplement is $1,143,121.
- Commission to Wainwright at 3.0% of gross proceeds; Company to reimburse expenses up to $100,000 plus due diligence fees.
- Offering terminates upon sale of $1.14M or termination by either party; Company not obligated to sell any shares.

## SEC filing metadata
- accession: 0001493152-24-038583
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224038583/0001493152-24-038583-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224038583/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038583
- JSON: https://secwatch.observer/filing/0001493152-24-038583.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038583.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.